Cargando…
Transcription activated p73-modulated cyclin D1 expression leads to doxorubicin resistance in gastric cancer
Gastric cancer (GC) is one of the leading types of cancer in terms of mortality cases worldwide. Doxorubicin (Dox), a common chemotherapy drug, is frequently used to treat GC; however, acquired resistance to Dox hinders the chemotherapeutic outcome and causes shorter survival in GC patients. Several...
Autores principales: | Ji, Zhi-Peng, Qiang, Ling, Zhang, Jian-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776556/ https://www.ncbi.nlm.nih.gov/pubmed/29434772 http://dx.doi.org/10.3892/etm.2017.5642 |
Ejemplares similares
-
CyclinD1 and p57(kip2) as biomarkers in differentiation, metastasis and prognosis of gastric cardia adenocarcinoma
por: Ru, Yi, et al.
Publicado: (2017) -
Transcription factor p73 regulates Th1 differentiation
por: Ren, Min, et al.
Publicado: (2020) -
ACOX1 destabilizes p73 to suppress intrinsic apoptosis pathway and regulates sensitivity to doxorubicin in lymphoma cells
por: Zheng, Fei-Meng, et al.
Publicado: (2019) -
Expression of cyclin D1 and cyclin E in human gastric carcinoma and its clinicopathologic significance.
por: Ahn, M. J., et al.
Publicado: (1998) -
p63 and p73 Transcriptionally Regulate Genes Involved in DNA Repair
por: Lin, Yu-Li, et al.
Publicado: (2009)